Public health experts are concerned about Fungal Infections cases caused by the fungus called Candida Auris in the U.S. The cases were reported in the country previously, but these new cases are concerning because of their resistance to existing drugs.
There have been cases where the Fungal Infections became resistant to drugs in patients who received treatment. The new cases were reported in the July 23 Morbidity and Mortality Weekly Report from the Centers for Disease Control and Prevention. Meghan Lyman, a medical officer in the mycotic diseases branch in CDC’s National Center for Emerging and Zoonotic Infectious Diseases, to STAT said that this is the first time that they have identified clusters of Fungal Infections with common health care exposures in the same facilities and among patients who had not received antifungals.
Lyman says that they tend to see transmission and see cases among patients who are in these high-acuity, long-term care facilities. They have very high-acuity, very sick patients like ones who are on ventilators or have tracheostomy or other invasive medical devices. Getting Covid and then having these complications put them at higher risk for acquiring Candida Auris.Treatment options for C. Auris are limited, and drug resistance has been a growing issue. If this evidence is what it seems, that could mean that the fungus can spread, and patients may develop infections that are potentially untreatable.